Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOWR-4: Titrating-Dose Lonafarnib/Ritonavir in Chronic Hepatitis Delta Virus
NCT02527707Phase 2Completed
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lonafarnib. Started Sep 2015; status: completed.
02
Drugs
lonafarnib
Beyond the preview
Go deeper on NCT02527707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527707.